Recently Viewed

  • Home
  • Stories
  • News Announcement
  • Cipla: Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
News Announcement

Cipla: Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015

20-Feb-2025 Follow Value Research Online on Google download pdfDownload PDF Cipla

Company has received final approval from USFDA for NDA submitted for Nilotinib Capsules 50 150 and 200 mg on 19th February 2025

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.